Abstract
An array of clinical events may lead to perioperative neurological injury. We first review the general cellular mechanisms leading to brain tissue injury and death. The genesis and mechanisms of injury after cerebral aneurysm surgery, traumatic brain injury, postoperative vascular insult in patients with severe cerebrovascular disease are discussed, as are strategies for prevention and treatment. More has become known about the epidemiology, risk factors and potential preventive strategies in postoperative delirium, and, to a lesser extent, postoperative cognitive dysfunction. Finally, emerging concepts in clinical brain protection are discussed, including preconditioning, gene therapy and stem cells.
Keywords: Hypoxic brain injury, aroxic brain injury, calcium-dependent cell death excitotoxicity, apoptosis, oxygen radicals, inflammatory response, IHAST trial, aneurysm surgery, cerebral vasospasan, re-bleeding, traumatic brain injury, hypothermin, cognitive dysfunction preconditioning
Current Pharmaceutical Design
Title:Cellular Mechanisms of Brain Injury and Cell Death
Volume: 18 Issue: 38
Author(s): Armin Schubert and Logan Emory
Affiliation:
Keywords: Hypoxic brain injury, aroxic brain injury, calcium-dependent cell death excitotoxicity, apoptosis, oxygen radicals, inflammatory response, IHAST trial, aneurysm surgery, cerebral vasospasan, re-bleeding, traumatic brain injury, hypothermin, cognitive dysfunction preconditioning
Abstract: An array of clinical events may lead to perioperative neurological injury. We first review the general cellular mechanisms leading to brain tissue injury and death. The genesis and mechanisms of injury after cerebral aneurysm surgery, traumatic brain injury, postoperative vascular insult in patients with severe cerebrovascular disease are discussed, as are strategies for prevention and treatment. More has become known about the epidemiology, risk factors and potential preventive strategies in postoperative delirium, and, to a lesser extent, postoperative cognitive dysfunction. Finally, emerging concepts in clinical brain protection are discussed, including preconditioning, gene therapy and stem cells.
Export Options
About this article
Cite this article as:
Schubert Armin and Emory Logan, Cellular Mechanisms of Brain Injury and Cell Death, Current Pharmaceutical Design 2012; 18 (38) . https://dx.doi.org/10.2174/138161212803832425
DOI https://dx.doi.org/10.2174/138161212803832425 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Extracellular Matrix on the Phenotypic Switching of Vascular Smooth Muscle Cells
Current Angiogenesis (Discontinued) Acute Stroke Therapy: Combination Drugs and Multifunctional Neuroprotectants
Current Neuropharmacology Drug Eluting Stents for Vulnerable Plague
Current Pharmaceutical Design Platelets in Rheumatic Diseases: Friend or Foe?
Current Pharmaceutical Design Contrast Enhanced Sonography for Diagnosis of (Peri-) Splenic Pathology
Current Medical Imaging A Novel Finding: Macrophages Involved in Inflammation Participate in Acute Aortic Dissection Complicated with Acute Lung Injury
Current Molecular Medicine Current Management of Neonatal Liver Tumors
Current Pediatric Reviews Aldose Reductase Inhibition: Emerging Drug Target for the Treatment of Cardiovascular Complications
Recent Patents on Cardiovascular Drug Discovery Proteomic Analysis of Liver Preservation Solutions Prior to Liver Transplantation
Current Proteomics Antibody Targeting of TGF-β in Cancer Patients
Current Pharmaceutical Biotechnology Mechanisms of Intimal Hyperplasia Learned from a Murine Carotid Artery Ligation Model
Current Vascular Pharmacology Implantable Medical Devices and Tissue Engineering: An Overview of Manufacturing Processes and the Use of Polymeric Matrices for Manufacturing and Coating their Surfaces
Current Medicinal Chemistry Magnesium as a Neuroprotective Agent in Cerebral Ischemia
Current Medicinal Chemistry - Central Nervous System Agents Prevention of Atherosclerosis by Interference with the Vascular Nitric Oxide System
Current Pharmaceutical Design Serpin Regulation of Fibrinolytic System: Implications for Therapeutic Applications in Cardiovascular Diseases
Cardiovascular & Hematological Agents in Medicinal Chemistry Genetics of Atherosclerosis in Murine Models
Current Drug Targets Essential Roles of Toll-Like Receptors in Atherosclerosis
Current Medicinal Chemistry Gender Differences in Types, Frequency, Clinical Manifestations and Atherosclerotic Burden of Coronary Artery Anomalies
Reviews on Recent Clinical Trials Use of Human Umbilical Cord Blood (HUCB) Cells to Repair the Damaged Brain
Current Neurovascular Research Molecular Mechanisms and Therapeutic Application of NSAIDs and Derived Compounds in Alzheimers Disease
Current Alzheimer Research